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Abstract
The opportunistic pathogen Pseudomonas aeruginosa can establish life-long chronic infections in the airways of cystic
fibrosis (CF) patients. Persistent lifestyle is established with P. aeruginosa patho-adaptive variants, which are clonal with the
initially-acquired strains. Several reports indicated that P. aeruginosa adapts by loss-of-function mutations which enhance
fitness in CF airways and sustain its clonal expansion during chronic infection. To validate this model of P. aeruginosa
adaptation to CF airways and to identify novel genes involved in this microevolution, we designed a novel approach of
positive-selection screening by PCR-based signature-tagged mutagenesis (Pos-STM) in a murine model of chronic airways
infection. A systematic positive-selection scheme using sequential rounds of in vivo screenings for bacterial maintenance, as
opposed to elimination, generated a list of genes whose inactivation increased the colonization and persistence in chronic
airways infection. The phenotypes associated to these Pos-STM mutations reflect alterations in diverse aspects of P.
aeruginosa biology which include lack of swimming and twitching motility, lack of production of the virulence factors such
as pyocyanin, biofilm formation, and metabolic functions. In addition, Pos-STM mutants showed altered invasion and
stimulation of immune response when tested in human respiratory epithelial cells, indicating that P. aeruginosa is prone to
revise the interaction with its host during persistent lifestyle. Finally, sequence analysis of Pos-STM genes in longitudinally P.
aeruginosa isolates from CF patients identified signs of patho-adaptive mutations within the genome. This novel Pos-STM
approach identified bacterial functions that can have important clinical implications for the persistent lifestyle and disease
progression of the airway chronic infection.
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Introduction
Persistent bacterial infections involving the opportunistic patho-
gen Pseudomonas aeruginosa are responsible for much of the morbidity
and mortality caused by cystic fibrosis (CF). After causing an initial
acute disease state, which is restricted by an immune response, P.
aeruginosa establishes persistent infection and colonizes the host by
evading immune surveillance [1] [2]. It has been shown that long-
term colonization of the CF host is maintained by P. aeruginosa
patho-adaptive lineages, which are clonal with the initially acquired
strain and carried phenotypic variants [3]. A number of genetic
mechanisms are responsible for generating clonal variants in P.
aeruginosa, including acquisition or loss of genomic islands, genome
rearrangements and recombinations [4]. Furthermore, point
mutations lead to a wide spectrum of morphotypes with very minor
genetic alteration [3]. Common mutations are consistently acquired
by most CF strains as those in regulators of alginate biosynthesis
(mucA and algU) [5] and virulence genes including motility (rpoN) [6],
in the quorum-sensing regulator (lasR) [7] [8], in the type-III
secretion system [9], in the multidrug-efflux pump (mexA) and in
mutator phenotypes (mutS) [10]. Most of these P. aeruginosa mutants
have morphotypes which are easy-to-follow by established in vitro
assays [11] while other patho-adaptive mutations have been
discovered by whole-genome comparison [3]. The sequence
analysis identified 68 mutations in the P. aeruginosa late isolate when
compared with its clonal early strain [3]. Most were single-base pair
changes and many were predicted to result in a change or loss of
protein function. Interestingly, virulence factors required for the
initiation of acute infections were selected against during chronic
infection. This indicates reduced virulence of the late strains with
regard to their ability to provoke acute infection [12] [13]. This
evolutionary scenario is similar to that of the genomes of other
pathogens from other species. Genetic loss-of-function mutations
confer enhanced fitness of the pathogen in a host-associated
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Helicobacter pylori [16].
Despite the importance of P. aeruginosa clones with adapted
virulence in the progression of CF airway disease, most patho-
adaptative mutations and their role in the persistent lifestyle
remain hidden in the genome due to the lack of genetic and
functional tools for large-scale screens. The widening gap between
the rapid progress in genome sequencing and the comparatively
slow progress in the functional characterization of sequenced
genomes represents a major concern to face the problem of P.
aeruginosa chronic infection in patients with CF [17]. Furthermore,
several different approaches, including signature tagged mutagen-
esis (STM), have been used to identify many bacterial genes
required for virulence but they are restricted to certain stages of
infection. STM is a genomics-based method for in vivo high-
throughput screening based on transposon mutants tagged with a
unique oligonucleotide. So far, STM has been based on a negative
selection approach and applied to animal models of short-term
acute infection. This approach selected and identified mutants
with attenuated virulence in a variety of different pathogens
[18,19,20]. According to the negative selection approach, mutants,
present in the inoculum but not in bacterial pools recovered from
short-term infected animals, are likely to be attenuated and
therefore altered within virulence genes. On the contrary, a
comprehensive screening of the bacterial genome for genes that
identify the stage of chronic infection and can be the targets of
phato-adaptative mutations has not been carried out. Progress in
this field requires the development of a novel approach for the
screening of STM libraries and sophisticated chronic infection
models suited to directly identify functions whose inactivation
promotes airways long-term chronic infection. Although several
mouse models have been developed to mimic the chronic
infection, the absence of CF-like lung disease, including long-term
infection supported by a significant number of bacteria, has been
disappointing [21]. We have recently reported that murine lung
pathology associated with chronic infection induced by P. aeruginosa
clinical strains isolated after years of colonization from CF
patients, differs significantly to that of PAO1 reference strain
[1]. In particular, exposure of murine airways to P. aeruginosa
clinical strains embedded in the agar beads caused a long-term
and higher rate of chronic infection than the challenge with the
PAO1 prototype strain. The presence of patho-adaptive mutations
in P. aeruginosa clinical strains and not in PAO1 may explain the
different pathology in this model of murine chronic infection.
Therefore, we designed a novel STM screening based on positive
selection by using P. aeruginosa PAO1 STM library as source of
mutants [22] and the validated agar beads mouse model of P.
aeruginosa chronic infection mentioned above [23] [1]. This
approach identified P. aeruginosa genes in PAO1 strain whose
inactivation enhanced the establishment and maintenance of
airways chronic infection similarly to clinical strains isolated
from patients with CF. The features of the genes identified
unmask novel strategies adopted by P. aeruginosa in the persistent
lifestyle.
Results/Discussion
STM positive selection screening for P. aeruginosa
mutations promoting long-term chronic airways
infection
We wished to track patho-adaptive mutations promoting long-
term P. aeruginosa infection in CF airways through the design of a
STM screening based on positive selection (Pos-STM) in vivo.A s
tool to mimic the initial and progressive bronchopulmonary
infection typical of CF patients, we used the validated agar beads-
mouse model of chronic infection [23] [1]. The time course
established previously with P. aeruginosa PAO1 [23] [1], and in this
work with a PAO1 derivative PAO1293, demonstrated that both
laboratory strains, given as doses ranging from 5610
5 to 5610
6
CFUs, induce low rates of acute mortality during the first three
days (PAO1: 24.1% and PAO1293: 20%) and show capacity to
establish chronic airways infection in some survivors (PAO1:
24.7% and PAO1293: 12.5%). Persistence vs clearance is taken as
a simple read-out of an established chronic infection in the
surviving mice at 14 days postinfection. To estimate bacterial
levels in the chronic infection, surviving mice are sacrificed, lungs
harvested, tissues homogenized and plated to evaluate bacterial
load. The recovery of an output pool of more than 10
3 CFUs of P.
aeruginosa is an indication of chronic infection as described
previously [23] [1]. Therefore, our criterion for the selection of
mutations in P. aeruginosa promoting chronic infection was the
screening for persistence rates higher than that of PAO1293
(12.5%) as described above. Indeed, we established, as criteria, to
consider positive in screening assay mutant output pools of
bacteria which persisted after several passages and at 14 days time
points (Fig. 1A).
The source of mutants was a P. aeruginosa PAO1293 STM mini-
Tn5 library constructed previously [22], consisting of 6912 clones.
In the first round of screening of the complete STM library
(Fig. 1B), mice were challenged with 96 input pools of 72 mutants
each. Since the large number of initial input pools, we decided to
challenge only two mice per pool and to consider positive those
challenges with at least one mouse with a chronic infection.
Output pools of STM-mutants from positive challenges were
further analyzed for clonal expansion of a given STM-mutant(s) by
multiplex PCR (see Material and Methods for details) using as a
template chromosomal DNA extracted from at least .10
3 pooled
bacterial colonies grown on agar plates. Following this first round
of screening, we identified from the initial 96 input pools, 21
positive output pools in which we detected variable numbers of
STM-mutants per pool, ranging from 72 (i.e. all mutants of the
pool) to 9, respectively, giving a total of 594 mutants. The number
of STM-mutants within a pool recovered after this initial screening
must take into consideration the potential of cooperative behavior
of virulence in mixed infection [1] [24]. The 594 STM-mutants
from the first screening were assembled into 21 novel input pools
and subjected to further rounds of in vivo screening. Since the input
Author Summary
Pseudomonas aeruginosa chronic infections cause persis-
tent respiratory symptoms and decline of the lung
functions in patients with cystic fibrosis (CF). Despite the
continuous immune response of the host defense and the
aggressive antibiotics treatment, bacterial persistence is
anyhow established after an acute infection stage. P.
aeruginosa establishes a permanent and detrimental
relationship with the host by pathogenic variants different
from the initially acquired strain. Currently, much is known
about the bacterial factors needed for acute infections
while the mechanisms involved in the colonization and
persistence in chronic airways infection remain mostly
unknown. The purpose of this study was to design a novel
approach of genomics-based method for in vivo high-
throughput screening to directly identify bacterial func-
tions whose inactivation promotes airways long-term
chronic infection. These studies may be relevant to the
design of future drugs acting against chronic infections.
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to five (per input pool) and selected for pools of STM mutants
which persisted in at least .50% of surviving mice. In the second
screening, we obtained 234 STM mutants, which distributed over
15 positive output pools with variable numbers of STM-mutants
per pool, ranging from 28 to 3. To proceed further, the 234 STM-
mutants resulting from the second screening were assembled from
the original STM library into 15 novel input pools and subjected
to further step of screening. As shown in Fig. 1B, the third round
of screening decreased the number of STM mutants to 34. Finally,
in the last round of screening, the 34 STM-mutants were tested
singly in larger groups of mice ranging from 10 to 15 animals and
with stringency for positive scoring of persistence increasing to
.70% of surviving mice. Sixteen of the 34 STM mutants were
confirmed as Pos-STM mutants, i.e. they caused a significant
increase in percentage of chronic infection in surviving mice when
compared to the PAO1293 wt (Chi square analysis: PAO1293 wt
vs Pos-STM mutants 12.5% vs 70–100%, p,0.05) (Fig. 2 and
Figure 1. Implementation of the Pos-STM screening. A) First round of screening of a P. aeruginosa PAO1293 STM mini-Tn5 library, consisting of
6912 mutants, arranged into 96 arrays of 72 mutants each [22]. The 72 P. aeruginosa mutants of each array were pooled, processed for agar beads
preparation and injected into C57BL/6NCrlBR mice (input pool). After 14 days from challenge, mice were sacrificed, and bacteria recovered from lungs
by plating homogenates. Bacterial cfu per lung and the percentage of infected mice were evaluated. B) In the first round of screening, clones that
infected at least one of the two mice were identified as positive and selected for the following rounds of screening. For the second screening, we
constructed 21 positive input pools with variable numbers of STM-mutants per pool, ranging from 72 to 9. Similarly, 15 positive input pools with
variable numbers of STM-mutants per pool, ranging from 28 to 3 were constructed for the third screening. Mice were infected in second and third
rounds of screening increasing to five the number of mice and selecting for more than 50% chronic infection. A total of 34 clones which passed the
third round were tested singularly in the fourth round increasing the stringency for positive scoring and using 10–15 mice per group. STM mutants
were identified by multiplex PCR. 16 mutants which increased significantly chronic infection (.70%) when compared to PAO1293 (12.5%) were
considered positive Pos-STM mutants and analyzed further.
doi:10.1371/journal.ppat.1001270.g001
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STM-mutants caused low mortality with no significant differences
compared to PAO1293 wt (Chi square analysis: PAO1293 wt vs
Pos-STM mutants 20% vs 10–53.3%, p.0.2).
Histopathological lesions of P. aeruginosa Pos-STM
mutants promoting long-term chronic airways infection
To assess clinical strain-traits of chronic infection, lung
histopathology was performed on mice challenged singularly with
the Pos-STM mutants for 14 days. The histopathological analysis
of P. aeruginosa Pos-STM-induced chronic pneumonia indicates
that in this model the lung was not totally compromised: the
infection was pluri-focal and generally involved one or more lung
lobes (Fig. 3A), whereas the others were unaffected or marginally
involved (Fig. 3B). Bronchi were filled by agar beads surrounded
by a massive neutrophilic infiltration (Fig. 3D) and the surround-
ing parenchyma was principally infiltrated by macrophages,
lymphocytes and neutrophils (Fig. 3E). In other cases bronchial
wall was disrupted with neutrophilic infiltration replaced by
‘foamy’ macrophages (Fig. 3F). The infected bronchi contained
fewer and smaller agar beads at 14 days when compared to day 0,
which were partially degraded by surrounding neutrophils and
released bacterial cells. Immunofluorescence staining observed at
confocal microscopy showed that the persisting bacterial cells were
localized within the bronchial lumen inside the beads (Fig. 3H)
and outside the beads as macrocolonies (Fig 3I). Therefore, some
of the persisting bacterial cells of the Pos-STM mutants were
protected from the murine respiratory defense system by the
biofilm formation and not by the beads. Furthermore, Pos-STM
mutant cells were presumably found invading inflammatory cells
(Fig 3J). Severities of lesions in the lung were similar between all
the Pos-STM mutants while most of the PAO1293 wt controls
resolved the infection and inflammation (Fig 3C, G and K).
Similar histopathological lesions were previously shown in murine
lung infected for 14 days with late isolates from CF patients [1].
These results indicate that single gene inactivation in PAO1293
can favor the establishment of chronic infection reminiscent of the
so-called ‘‘unique’’ strain lineages of P. aeruginosa pathogenic
variants isolated from CF patients.
Analysis of the Pos-STM mutants revealed transposon
insertions within known virulence genes and other genes
not previously associated to infection
Each Pos-STM mutant was subjected to mapping of the
transposon insertion by sequencing of the mini-Tn5 flanking
genomic regions (Table S1 in Text S1). This first analysis
individuated single insertions within a specific gene in 15 Pos-STM
mutants (Table 1) and a single insertion into the intergenic region
between loci PA0436 and PA0437 in the remaining Pos-STM
mutant. However, a further test by Southern blotting to ensure
that the Pos-STM mutants did not carry more than one
transposon insertion showed that mutants 70T5K and 70T15K
carried one additional mini-Tn5 insertion that eluded the previous
analysis of mapping (Table 1).
The 15 mini-Tn5 inserted genes encoded proteins from almost
all functional classes (Table S3 in Text S1): hypothetical,
unknown, unclassified proteins (PA2972, PA4842, PA5028),
motility and attachment (PA0410-pilI, PA0499, PA1077-flgB,
PA4554-pilY1), putative enzymes (PA1856), transport of small
molecules (PA0890-aotM, PA2252, PA4887), amino acid bio-
synthesis and metabolism (PA0895-aruC), energy metabolism
(PA2998-nqrB), secreted factors (PA3478-rhlB), chaperones and
heat shock proteins (PA5053-hslV). However, we noted that some
insertions map into either the first or internal genes of certain
operons, as listed in Table S3 in Text S1, and polar effects on the
expression of downstream genes could account for the observed
phenotype. In the case of mutants 70T5K and 70T15K, the Pos-
STM phenotype can be due to a combination effect caused by the
double insertion and or recombination events. Finally, since the
intergenic transposon insertion in the 70T22T STM mutant is
between convergent PA loci, we speculate a negative effect of the
insertion on transcription termination. Furthermore, inactivation
of small non coding RNA gene(s) cannot be ruled out.
Interestingly, previous report showed that eight different intergenic
regions were mutated in the 96-month isolate from CF patients
[3].
In a second step of analysis, the 16 Pos-STM mutants were
tested for the following traits, known to play an important role in
the P. aeruginosa pathogenesis of CF infections: motility, mucoidy,
hypermutability, protease secretion, siderophore, hemolysis, au-
tolysis, pyocyanin production, biofilm formation and LasR
phenotype, consisting of visible accumulation of the iridescent
intercellular signal 4-hydroxy-2-heptylquinoline due to loss-of-
function inactivation of lasR. The results of these analyses are
summarized in Table 1 and Table S4 in Text S1. No Pos-STM
mutant showed mucoid and LasR phenotypes, or defects in
protease secretion and siderophore production. On the contrary, a
significant proportion of mutants in functions associated with
motility emerged in this screening. In fact, three Pos-STM mutants
carried insertions in PA0410-pilI and PA4554-pilY1, involved in
type IV pilus biogenesis, and in PA1077-flgB, coding for the
flagellar basal-body rod protein. Moreover, the Pos-STM mutant
in PA2972 coding for an hypothetical protein was found to be
Figure 2. Virulence of P. aeruginosa Pos-STM mutants in a
murine model of airways infection. C57Bl/6NCrlBR mice were
infected with Pos-STM P. aeruginosa mutants embedded in agar beads.
Mortality induced by bacteremia (red) and survival (grey) were
evaluated on challenged mice. Clearance (white) and capacity to
establish chronic airways infection (green) after 14 days from challenge
were determined on surviving mice. The data show the percentage of
mice infected with P. aeruginosa pooling together two to three
independent experiments (PAO1293 wt: n=10; STM mutants n=10–
15). Statistical significance by Chi square is indicated: *p,0.05,
**p,0.01, ***p,0.001.
doi:10.1371/journal.ppat.1001270.g002
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loss of motility favors the establishment and maintenance of
chronic infection, are consistent with other studies. On the one
hand, lack of motility is one of the phenotypes acquired by P.
aeruginosa isolates over the course of CF airway infection and
increases the risk of chronic infection in animal models [3] [1]. On
the other hand, it was shown that the risk of bacteremia is
increased by the presence of pili and flagella since they confer a
selective advantage for spreading from the lung to other organs
[25] [1] [26]. In addition to motility, flagella and pili also provide a
ligand for phagocytic clearance [25]. Moreover, there is another
striking consistency of our data with a previous P. aeruginosa STM
screening in a polymorphonuclear neutrophil (PMN) phagocytosis
assay [27]. In that case, two independent STM-mutants in pilY1
arose from the screening since they showed higher survival rates
(i.e. more resistant to killing by PMNs) than the wild type and any
of the 3500 tested STM-mutants. In murine model, inactivation of
pilY1 impacted virulence promoting P. aeruginosa persistence in the
airways [27]. Taken together, these consistencies validate our Pos-
STM approach and strongly indicate its robustness for the
identification of novel genes which impact the genetic adaptation
of P. aeruginosa in CF airways.
Pyocyanin secretion defects were found in the PA4554-pilY1
mutant, as expected from a previous report [27], and in the
PA4842 mutant. Finally, regarding biofilm formation, PA4554-
pilY1 and PA1077-flgB mutants showed low levels of biofilm,
respectively. This was not surprising given the involvement of
flagella and pili in biofilm development by P. aeruginosa [28]. On
the contrary, PA3478-rhlB and PA0890-aotM showed an improved
ability to form biofilm. The remaining nine Pos-STM mutants
showed no alteration in motility, pyocyanin secretion, and biofilm
formation. As in the case of pilY1 mutants, higher fitness to
colonize and persist in airways may be multifactorial. This may
also be true for PA3478-rhlB and PA0890-aotM mutants. One key
factor for chronic infection could be the improved capacity to form
biofilm. Other factors may be directly related to the inactivation of
rhlB and aotM genes, respectively, as described below. The rhlB
gene encodes RhlB rhamnosyltransferase [29], an enzyme
involved in the synthesis of the surfactant mono-rhamnolipids
(RLs) [30]. Among their roles, RLs have been shown to act as
immune modulators and virulence factors. It has been demon-
strated that purified RLs act directly on immune cells. For
instance, they have been shown to induce direct neutrophil
chemotactic activity, to stimulate the copious release of interleukin
IL-8, granulocyte-macrophage colony stimulating factor and IL-6,
and to induce the lysis of PMNs. Therefore, the inactivation of rhlB
gene could attenuate the bacterium and allow it to evade the
immune system. The reduced ability to induce IL-8 secretion was
assessed for the PA3478-rhlB mutant (see below). Whereas, the
improved fitness for chronic infection of PA0890-aotM mutant
may be more closely-related to bacterial metabolism. In fact, the
aotM gene codes for a component of the arginine/histidine ABC
transporter, involved in the catabolism of arginine and controlled
by ArgR and L-arginine under aerobic conditions [31]. Inactiva-
tion of aotM may stimulate the anaerobic catabolism of arginine by
the arginine deiminase (ADI) pathway [32] and thus enhance the
fitness for the colonization of and the persistence in the airways.
The same effect may be possible for PA0895-aruC mutant. In fact,
aruC codes for N-succinylglutamate 5-semialdehyde dehydroge-
nase involved in the aerobic arginine utilization via the arginine
succinyltransferase (AST) pathway [33]. Remarkably, P. aeruginosa
anaerobic catabolism of arginine can be relevant for colonization
Figure 3. Murine lung histology and localization of P. aeruginosa Pos-STM mutants after 14 days. Mice were infected with 2610
6 cfu/lung
of P. aeruginosa Pos-STM strains embedded in agar beads. In this panel, PA5053- hslV (A and B), PA2998-nqrB (D and H), PA4554-pilY1 (E and I) and
PA0499 (F and J) are taken as representative of the whole set of 16 Pos-STM mutants. Control mice were infected with PAO1293 wt (C, G and K).
The lungs were stained with H&E (A–G) or with specific antibody against P. aeruginosa strains (red) (H–K). Counterstaining was performed with 49,6-
Diamidino-2-phenylindole dihydrochloride (DAPI) (blue) (H–K). Bronchi and pulmonary parenchyma are characterized by chronic lesion (*) infiltrated
by macrophages, lymphocytes and neutrophils. Severity of lesions and lung involvement is heterogeneous in different lobes of the same mice (A
and B). Bronchi contain massive granulocyte infiltration of bacteria and agar beads (arrow) (D and H) or bronchial wall is disrupted and the
bronchial lumen is filled by foamy macrophages and bacteria presumably internalized by inflammatory cells (F and J). Bacterial macrocolonies are
visible in the pulmonary parenchyma outside the beads (E and I). PAO1293 wt infected mice resolved the infection and inflammation (C, G and K).
A–C: 2.56; D–K: 206; insert I–J: 636. Confocal microscopy (H–K). Bars, 100 mm.
doi:10.1371/journal.ppat.1001270.g003
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induced metabolic rearrangements could also involve other Pos-
STM mutants. For instance, inactivation of PA1856, coding for a
probable cytochrome c oxidase cbb3-type (subunit I), or PA2998-
nqrB, coding for Na(+)-translocating NADH-quinone reductase
subunit B, may rearrange the P. aeruginosa branched (micro)aerobic
respiratory chain [35]. Furthermore, inactivation of PA2252,
coding for a probable AGCS sodium/alanine/glycine symporter,
or PA4887, coding for a probable major facilitator superfamily
(MFS) transporter, may induce a metabolic reset better suited to
colonize and persist in airways. Interestingly, another probable
MFS transporter (PA2092) was mutated in the 96-month isolates
from CF patients [3].
The significantly high number of Pos-STM mutants in genes
related to metabolic functions strongly supports a key role of
bacterial metabolic adaptation during chronic infections. This
notion was raised previously [7] for mutations inactivating lasR,
one of the most common targets of mutation in P. aeruginosa CF
isolates [3]. The lasR loss-of-function mutations in these strains
confer a growth advantage with particular carbon and nitrogen
sources, including amino acids [7]. This growth phenotype was
supposed to contribute to positive selection of lasR mutants within
CF airways.
On the whole, as suggested previously by the analysis of P.
aeruginosa isolates over the course of CF airways infection, the
characterization of the panel of the Pos-STM mutants strongly
indicates that chronic-adapted phenotypes reflect alterations in
different aspects of the bacterium’s biology. Remarkably, our Pos-
STM screening did not detect mutants in functions associated with
the alginate biosynthesis resulting in a mucoid phenotype, or with
mismatch-repair systems giving rise to hypermutability. These two
phenotypes usually appear relatively late in the chronic infection
[10] [5] and it is possible they might not be critical for the
establishment and the early stages of chronic infection. Further-
more, the Pos-STM screening may be affected by other factors
limiting the technology as discussed in the conclusion below.
Cellular invasion and stimulation of the host immune
response by Pos-STM mutants
CF airway chronic infections occur with P. aeruginosa genetic
variants and depend on the ability of bacteria to resist the host
defense [1] [2]. For these reasons, in addition to the bacterial
phenotypes analyzed above, we tested the ability of the Pos-STM
mutants to invade human respiratory epithelial cells and to
stimulate an immune response. As shown in Figure 4A,1 1o f1 6
Pos-STM mutants were found to be significantly more invasive
than the reference PAO1293 wt strain. On the contrary, PA3478-
rhlB and PA0890-aotM mutants were found to have a non-invasive
phenotype. This feature may be related to the production of
higher levels of biofilm by these strains. Other Pos-STM mutants
showing limited invasiveness as PAO1293 wt were found in
PA2972 and PA5028. Finally, PA4554-pilY1 was found to be
significantly less invasive in A549 cells than PAO1293 wt.
When the bacteria-induced IL-8 secretion was tested in A549
cells, most of the Pos-STM mutants were found to induce lower
stimulation of IL-8 secretion. Significant differences were obtained
Table 1. Genotypic and phenotypic characterization of Pos-STM mutants.
STM-mutant Number of Tn insertions PA number
a Gene name Relevant phenotype
b
4T24K 1 PA0410 pilI Swimming and twitching defect
4T9G 1 PA0499 - -
13T9G 1 PA0890 aotM Increased biofilm formation
70T15K 2 PA0895 aruC -
nd
c
13T22K 1 PA1077 flgB Swimming defect
Decreased biofilm formation
22T18G 1 PA1856 - -
31T23K 1 PA2252 - -
13T18G 1 PA2972 - Twitching defect
4T16K 1 PA2998 nqrB -
4T5T 1 PA3478 rhlB Increased biofilm formation
22T13K 1 PA4554 pilY1 Swimming and twitching defect
Pyocyanin secretion defect
Decreased biofilm formation
70T5K 2 PA4842 - Pyocyanin secretion defect
nd
c
31T4T 1 PA4887 - -
22T4G 1 PA5028 - -
22T9K 1 PA5053 hslV -
70T22T 1 PA0436-PA0437 IR
d --
alocus ID according to Pseudomonas Genome DatabaseV2 (www.pseudomonas.com).
brelevant phenotype of Pos-STM mutants compared to PAO1293 wt.
cnot determined.
dintergenic region.
doi:10.1371/journal.ppat.1001270.t001
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when compared with PAO1293 wt (Figure 4B). Therefore, the
majority of mutants showed increased invasiveness and/or lower
stimulation of IL-8 secretion. Together, these results indicate that
invasion of host cells and/or lower stimulation of IL-8 secretion
can be instrumental to the higher fitness to colonize and persist in
CF airways.
Consistently with data obtained in P. aeruginosa clinical strains
[2] and strategies used by a number of other bacterial pathogens
[36,37,38], it is feasible that Pos-STM mutants acquired
mechanisms for cellular invasion. Internalization in a host could
benefit bacterial survival through evasion of host phagocytic- and
antibody/complement-mediated killing mechanisms. Intracellular
survival is a key component in the pathogenic cycle of a number of
bacterial pathogens, including Mycobacteria spp., Shigella flexneri,
Salmonella spp., Legionella pneumophila and Burkholderia cenocepacia [39]
[40] [41]. Furthermore, in CF disease, decreased internalization of
P. aeruginosa in CFTR deficient cells may increase bacterial lung
burdens and contribute to establish biofilm-mediated chronic
infection [42] [43].
Several lines of evidence indicate that, to permit long-term
colonization, there has been selective pressure on pathogens to
avoid triggering an intensive inflammatory reaction. Comparing
lipid A and peptidoglycan of sequential strains isolated from CF
patients, we recently showed that P. aeruginosa has evolved the
capacity to evade immune system detection [2]. In this study, we
extended this notion showing that the majority of Pos-STM
mutants reduced the immune stimulatory potential. These findings
emphasize further studies to establish whether P. aeruginosa adapted
mutants evade immune system thus promoting survival and
establishing favourable conditions for chronic persistence in CF
patients.
Pathoadaptive mutations in P. aeruginosa clinical strains
from CF patients
Next, we asked whether the mutations observed in our Pos-
STM approach are, to the some extent, representative of patho-
adaptive mutations associated with P. aeruginosa infections in CF
patients. To address this issue, we set out to sequence the 15 genes
which were inserted in the Pos-STM mutants in a collection of
longitudinal isolates from seven different CF patients; they include
early strains isolated at the onset of chronic colonization and late
strains collected over a period of up to 16.3 years [5]. Out of 15,
we could obtain the full-length sequence of 14 genes. In fact, we
were unable to amplify by PCR the full-length pilY1 gene sequence
throughout the collection of the P. aeruginosa longitudinally isolates.
We attempted to amplify internal gene regions. The sequence
analysis of the few PCR fragments that we obtained indicated
several changes involving the pilY1 gene. Thus, this strongly
indicated that pilY1 gene underwent extensive changes in the
clinical isolates. Sequences analysis of the remaining genes by
comparison between early and late strains revealed single base-
pair synonymous and non-synonymous mutations in seven of 14
genes in six different clonal lineages (See Table 2 and Table S5
in Text S1 for the complete panel of mutations). Non-
synonymous mutations were found in five genes (PA0895-aruC,
PA1856, PA2252, PA3478-rhlB and PA4887) from five different
clonal lineages of CF patients (Table 2). A computational method
for predicting the effect of each non-synonymous mutations on
protein function [44] suggested that the non-tolerated changes in
PA0895-aruC, PA3478-rhlB and PA4887 are likely to affect protein
function (Table S5 in Text S1). P. aeruginosa clonal isolates from a
single time point after long-term chronic infection were hetero-
geneous, indicating a genetic diversification of a single strain
during growth in CF airways as previously reported [3]. Overall,
these data hint that some Pos-STM mutations, might recapitulate
patho-adaptative mutations occurring in P. aeruginosa clinical
strains. Previous studies have shown that well-known pathoadap-
tative mutations in loci including for instance mucA [5], LasR [7] or
mutS [10] are common but not acquired by all P. aeruginosa isolates
from CF patients. These observations have supported the notion
that a number of genes in the genome are targets for patho-
adaptative mutations promoting CF airways chronic infection,
although most of these genes are mutated in only a fraction of
bacterial strains isolated from infections. Therefore, the analysis of
significant rates of the patho-adaptative mutations in Pos-STM
genes identified in this study could require the study of broader
collections of longitudinal P. aeruginosa isolates from CF patients.
Conclusions
For the first time in an animal model of chronic lung infection
by P. aeruginosa, an STM approach based on positive selection is
presented. The main objective of this work was to address the
genetic adaptation within a defined genetic system of P. aeruginosa
in CF airways through loss-of function mutations in virulence
factors and regulators. As with typical STM, the Pos-STM is a
screening assay and has limitations. For instance, Pos-STM can be
Figure 4. Stimulation of A549 with P. aeruginosa Pos-STM
mutants. A) Fold of invasion relative to PAO1293 after 2 h of
stimulation with Pos-STM mutants. B) IL-8 secretion was quantified by
ELISA after stimulation with Pos-STM mutants for 2 h. Measurements
were performed in triplicate. *p,0.05, **p,0.01, ***p,0.001 in the
Student’s t-test.
doi:10.1371/journal.ppat.1001270.g004
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complementation between cells growing in vivo. Bacteria cells that
are not necessarily enhanced in establishing chronic infection can
be maintained by those that are. This can be overcome by using
several rounds of screening and diminishing the number of
mutants per pool as done here. Other limitations include the
concentration of bacteria in the inoculum, the limited number of
initial STM mutants (6912 mutants in this case). Obviously, the
collection of STM mutants used is not representative of the
complete genome but covers a small fraction of genes. Genes not
in the STM collection will not be selected by Pos-STM. Other
factors limiting this technology include the time points selected
after infection to recuperate bacteria and the selective pressure for
the bacterial growth in the agar beads mouse model. As a result,
we identified 16 insertion mutations which lead to an increase in
the fitness to promote chronic infection. This panel of mutants
shows directly that P. aeruginosa establishes and maintains long-
term chronic infection with patho-adapted variants. The reliability
and robustness of our Pos-STM approach is supported by the high
proportion of mutations in motility-related functions which are
known key players in the pathogenesis of P. aeruginosa. Remark-
ably, our findings rigorously support the previous hypothesis that
virulence factors essential for acute infection are lost when P.
aeruginosa establishes long-term chronic infection. In addition to
this, our screenings resulted in the identification of novel genes
which were not previously associated to infection. Thus, our novel
approach provides the basis to investigate the P. aeruginosa
pathogenesis further and to extrapolate the results to other
bacterial pathogens. The significantly high number of these genes
linked with metabolic functions reinforces the notion of a key role
played by P. aeruginosa metabolic adaptation during chronic
infection. Furthermore, the behaviour of the majority of our
Pos-STM mutants on host cells suggests that invasiveness and/or
altered stimulation of the immune response influence the fitness to
colonize and persist in CF airways. The fact that many of these
bacterial functions have been missed in the other screenings,
including large-scale DNA sequencing [3] and morphological
phenotypes assays [3], emphasizes the gap of tools for profiling
chronic infection and points to the need to perform this novel Pos-
STM approach.
Finally, some of the genes of this STM screening were found to
be mutated throughout a collection of longitudinal isolates from
CF patients. This hints that they may be targets of patho-adaptive
mutations during the P. aeruginosa microevolution during CF lung
infection with major implication in the progression of the lung
disease. The novel approach of positive-selection screening,
described for the first time in this study, should find general
applicability to other pathogens that enhance fitness in their host
through patho-adaptive mutations and so provide a basis for more
comprehensive understanding of chronic infection diseases.
Materials and Methods
Ethics statement
Animal studies were conducted according to protocols approved
by the San Raffaele Scientific Institute (Milan, Italy) Institutional
Animal Care and Use Committee (IACUC) and adhered strictly to
the Italian Ministry of Health guidelines for the use and care of
experimental animals.
Research on the bacterial isolates from the individual with CF
has been approved by the responsible physician at the CF center at
Hannover Medical School, Germany. All patients gave informed
consent before the sample collection. Approval for storing of
biological materials was obtained by the Hannover Medical
School, Germany.
Bacterial strains
The P. aeruginosa PAO1/PAO1293 STM library was described
previously [22]. PAO1293 is a derivative of PAO1 from the
Holloway laboratory [45] and carries the E79tv-2 giving
chloramphenicol susceptibility. STM mutants were cultured at
37uC in brain-heart infusion (BHI) or on TSB agar plates
containing 300 mg/ml kanamycin or 25 mg/ml tetracycline. For
agar beads preparation, STM mutants were grown in BHI broth
in a 96-well plate at 37uC for 18h, pooled, centrifuged at
4000 rpm for 10 min and re-suspended at a concentration of
approximately 5610
9 cfu/ml. P. aeruginosa clinical strains were
isolated from CF patients as described previously [5] [1].
Pos-STM screening in a mouse model of chronic infection
C57Bl/6NCrlBR (Charles River) (6–8 weeks) male mice were
infected with STM mutant loads ranging from 5610
5 and
2.5610
6 CFUs of P. aeruginosa embedded in agar beads and
infected as previously described [23]. Fourteen days after infection,
murine lungs were excised, homogenized and plated onto TSB-
agar plates for cfu counting and identification. For STM mutant
Table 2. Gene sequence comparison between early and late P. aeruginosa isolates from CF patients.
Gene
name PA number Gene function Clinical strain*
No. of nonsynonymous
mutations aa mutation
aruC PA0895 N-succinylglutamate 5-semialdehyde
dehydrogenase
TR1 vs TR67 1 G197-V
- PA1856 putative enzyme AA2 vs AA43, AA44 2 V97 - A, I180 - M
BT2 vs BT72, BT73 2 A97 - V, M180 - I
- PA2252 probable AGCS sodium/alanine/
glycine symporter
AA2 vs AA43 1 M4 - K
KK1 vs KK72 2 R464 – H, N480 - T
rhlB PA3478 rhamnosyltransferase chain B KK1 vs KK71 1 H201 - Q
- PA4887 probable major facilitator
superfamily (MFS) transporter
SG1 vs SG57 2 K18 – V, K18 – V
SG1 vs SG58 2 K18 – M, L212 - M
*Strains were collected at the onset of chronic colonization (numbered 1–2 per patient) or after 4–18 years of chronic airway colonization (numbered 43–73) [5] [1].
doi:10.1371/journal.ppat.1001270.t002
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4 bacterial colonies grown on agar
plates were pooled from each positive output pools and subjected
to chromosomal DNA extraction and multiplex PCR analysis
according to established protocol [22]. For confirmation, the PCR
was repeated for each putative STM mutant.
Histological examination and immunofluorescence
Lungs were removed, fixed in 10% buffered formalin for at least
24 h and embedded in paraffin. Consecutive 2-mm sections from
the middle of the five lung lobes were used for histological and
immunofluorescence examination in each mouse. Sections for
histological analysis were stained by Haematoxylin-Eosin and
examined blindly. Localization of P. aeruginosa was performed in
de-paraffinized lung sections by employing a rabbit antiserum
specific for P.aeruginosa and Texas Red-labelled goat anti-rabbit
IgG as described [1]. Immunofluorescence images were recorded
with an EM-CCD Hamamatsu C9100 CCD camera (Hamamatsu
Photonics, Hamamatsu City, Japan) mounted on an UltraVIEW
Spinning Disk Confocal Microscope (Perkin Elmer, Waltham,
MA, USA). Slides stained with haematoxylin and eosin were
visualized with Axioplan2 (Zeiss, Jena, Germany) with AxioCam
provided with the CCD MRc5 (Zeiss).
Sequencing transposon flanking regions
Transposon flanking regions were amplified by the Y-linker
method [46]. Approximately 40 ng of genomic DNA, digested
with NlaIII, was ligated to 1 mg of Y linker with T4 DNA ligase in
a final volume of 20 ml. After overnight incubation at 16uC, 1 mlo f
the reaction mixture was used as template for hot-start PCR
amplification, using a transposon specific oligos (pUTKana2;
pUTgfpR2) [22] and the Y-linker specific Y-primer oligo (Table
S1 in Text S1). The PCR product was purified from agarose gel
with QIAquick Gel Extraction Kit (Qiagen) and then sequenced
by Eurofins MWG-Operon (Germany).
Phenotypic characterization
Motility and analysis for LasR mutants were evaluated as
described [28] [7]. Mutation frequency measurement were
determined by rifampicin assay [10] [47]. Protease and side-
rophore secretion, pyocyanin, mucoidy, and biofilm formation
assay haemolytic/autolytic activity were assayed as described in
the online data supplement.
Gene sequencing and computational tools
P. aeruginosa clinical strains described previously [5] [1] were
used to sequence the genes inserted in the Pos-STM mutants. PCR
genes amplification was carried out using the primers listed in
Table S1 in Text S1. The amplified DNA samples were
sequenced by standard automated DNA sequence technology.
The sequence results were compared within P. aeruginosa clonal
lineages with BioEdit v7.0.5 to determine the occurrence of
sequence variants within the selected genes. The program SIFT
was used to predict the effect of non-synonymous mutations on
protein function [44].
Cell cultures and invasion assay
The A549 (human type II pneumocytes) cell line was purchased
from ATCC CCL-185 and cultured as described [48]. Bacteria
invasion assay was performed using ceftazidime-amikacin protec-
tion assay with minor modifications [48]. P. aeruginosa strains,
grown to the mid-exponential phase, were used to infect cell
monolayers at a 100:1 multiplicity of infection for 2h. The
monolayers were washed with PBS, treated with antibiotic for 2 h,
washed, lysed with H2O and plated on TSB-agar plates (Difco).
IL-8 secretion
IL-8 was determined in supernatants collected from the cell
cultures described above using an ELISA kit (Biosource Europe).
According to the manufacturer the sensitivity of the assay is less
than 0.7 pg/ml. Values were normalized to 10
6 cells; results were
expressed as mean 6 SD.
Statistical analysis
Statistical calculations and tests were performed using Student’s
t-test and the Chi-square test considering p,0.05 as the limit of
statistical significance. All data were expressed as mean +/2
standard deviation (SD).
Supporting Information
Text S1 Material and methods concerning phenotypic and
genetic characterization of Pos-STM mutants, list of primers used
for identification and sequencing of P. aeruginosa Pos-STM mutants
and clinical strains (Table S1), virulence of P. aeruginosa Pos-STM
mutants in a murine model of airways infection (Table S2),
Classification of Pos-STM inserted genes by molecular function
(Table S3), Phenotypic characterization of P. aeruginosa Pos-STM
mutants and interaction with human cells (Table S4), Pos-STM
genes in which mutations occurred during chronic airways
infection in CF patients (Table S5).
Found at: doi:10.1371/journal.ppat.1001270.s001 (0.29 MB
DOC)
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